Does Zepbound Cause Heartburn? What the Label Reports
Does Zepbound cause heartburn? It can: the Zepbound label lists heartburn and gastroesophageal reflux disease (GERD) among its side effects. In the Mounjaro label, which is the same drug, tirzepatide, reflux disease was reported by 1.7% to 2.5% of people on the drug against 0.4% on placebo.
The dose-by-dose reflux figures on this page come from the Mounjaro label. Zepbound and Mounjaro both contain tirzepatide; the Mounjaro trials were in adults with type 2 diabetes.
Short answer
- Is heartburn on the label?
- Yes. The Zepbound patient information lists heartburn, and the prescribing information names gastroesophageal reflux disease.
- How common, by the label figures
- In the Mounjaro label (same drug), reflux disease was 1.7% to 2.5% on tirzepatide against 0.4% on placebo.
- When it tends to happen
- No source gives a duration. Stomach side effects are more likely at the start and when the dose goes up, says a 2025 joint advisory.
- When to see a doctor
- NIDDK says to see a doctor if you think you have GERD, or if symptoms do not improve with over-the-counter medicines or lifestyle changes.
Sources: Zepbound FDA label; Mounjaro FDA label; Joint nutrition advisory, Obesity 2025; NIDDK, acid reflux symptoms and causes
Heartburn and reflux on the Zepbound label
The Zepbound label names both. Its patient information lists heartburn, and its prescribing information lists gastroesophageal reflux disease.
The patient information list of side effects reads: nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss and heartburn.
The prescribing information uses the medical names for the same group: dyspepsia, eructation (belching) and gastroesophageal reflux disease sit on the same list as nausea, diarrhea and the rest.
Heartburn is the main symptom of reflux. NIDDK, part of the US National Institutes of Health, describes it as a painful, burning feeling in the middle of the chest, behind the breastbone, rising toward the throat.
Sources: Zepbound FDA label; NIDDK, acid reflux symptoms and causes
How common is reflux on tirzepatide? The Mounjaro label figures
In the Mounjaro label, reflux disease was reported by 1.7% to 2.5% on tirzepatide and 0.4% on placebo. Belching and gas were also more common on the drug.
| Side effect | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Gastroesophageal reflux disease | 0.4% | 1.7% | 2.5% | 1.7% |
| Belching (eructation) | 0.4% | 3.0% | 2.5% | 3.3% |
| Gas (flatulence) | 0% | 1.3% | 2.5% | 2.9% |
Disclaimer: these are trial doses from the label, not a recommendation. Dose decisions belong with a licensed clinician.
Reflux did not rise neatly with the dose. It was highest on 10 mg (2.5%) and the same on 5 mg and 15 mg (1.7%). The 2025 joint advisory says higher doses are more likely to provoke stomach side effects in general, but for reflux in this table the pattern is flat.
Why Mounjaro figures? We use the Mounjaro table because its figures by dose could be quoted exactly, and it is the same medicine. For how the two brands compare, see is Zepbound the same as Mounjaro. The dose steps are in our tirzepatide dosage guide.
Sources: Mounjaro FDA label; Joint nutrition advisory, Obesity 2025
Why can Zepbound cause heartburn?
One proposed link is a slower stomach. The Zepbound label says tirzepatide delays gastric emptying, and a 2025 study in Annals of Internal Medicine calls delayed gastric emptying a risk factor for GERD.
Slower emptying also matters for other pills. The Zepbound label says it has the potential to change how other medicines taken by mouth are absorbed.
Weight itself plays a part in reflux. NIDDK lists being overweight or having obesity, being pregnant, and smoking or breathing secondhand smoke among the factors that can affect the lower esophageal sphincter, the valve at the bottom of the food pipe, and lead to GERD.
Sources: Zepbound FDA label; Ann Intern Med 2025 cohort; NIDDK, acid reflux symptoms and causes
What cohort studies of GLP-1 drugs found about reflux
Three cohort studies looked at reflux in GLP-1 drug users. Two compared them with other groups and found a higher risk. None looked at tirzepatide on its own.
| Study | Who | Finding | Covers tirzepatide? |
|---|---|---|---|
| Ann Intern Med 2025 | Type 2 diabetes, GLP-1 drugs vs SGLT-2 inhibitors, median 3.0 years | GERD risk ratio 1.27, an extra 0.7 cases per 100 patients | GLP-1 class, not tirzepatide alone |
| Gut 2024 | Type 2 diabetes, matched cohort | Erosive reflux hazard ratio 1.15 overall, driven by short-acting drugs (1.215), not long-acting (0.994) | GLP-1 class, not tirzepatide alone |
| Dig Dis Sci 2026 | Real-world GLP-1 users, one year | New GERD in 8.7%; any stomach side effect in 31.9% | GLP-1 class, not tirzepatide alone |
In plain numbers: the Annals study found about 0.7 extra cases of GERD per 100 patients over a median of 3 years, compared with people on SGLT-2 inhibitors. Its risk ratio for reflux complications was 1.55, an extra 0.8 per 1,000 patients.
The Gut study found the higher risk of erosive reflux came only from short-acting GLP-1 drugs, not long-acting ones. All three studies are about the drug class, mostly in people with type 2 diabetes. They cannot tell you the risk for tirzepatide alone.
Sources: Ann Intern Med 2025 cohort; Gut 2024 cohort; Dig Dis Sci 2026 real-world study
How long does Zepbound heartburn last?
No label or study we found gives a duration for heartburn on tirzepatide. The timing data that exist are for stomach side effects as a group.
- The Zepbound label says most people who stopped Zepbound because of side effects did so in the first few months of treatment, due to stomach side effects.
- The 2025 joint advisory says stomach side effects are generally more likely when a GLP-1 is started or the dose is raised.
Neither source says heartburn fades by a set week. If it keeps going, that is a reason to talk to a doctor, as the last section explains.
Sources: Zepbound FDA label; Joint nutrition advisory, Obesity 2025
How to avoid heartburn on Zepbound: what the sources say
No study has tested a way to prevent heartburn on Zepbound. The guidance that exists is general reflux advice from NIDDK, plus one GLP-1 point on alcohol.
NIDDK says your doctor may recommend:
- Losing weight, if you are overweight or have obesity.
- Raising your head during sleep by 6 to 8 inches, with a foam wedge or extra pillows under your head and upper back.
- Quitting smoking, if you smoke.
On GLP-1 drugs specifically, the 2025 joint advisory says alcohol may worsen nausea and gastroesophageal reflux, and should be minimized.
For meal size and food guidance on these drugs, see GLP-1 meals. If the problem is more burping than burning, see Ozempic burps.
Sources: NIDDK, acid reflux treatment; Joint nutrition advisory, Obesity 2025
Antacids and tirzepatide
NIDDK says doctors may recommend antacids for mild heartburn. It also says they should not be used every day or for severe symptoms, except after talking with your doctor.
No official source we found covers antacids with tirzepatide directly. The Zepbound label says tirzepatide delays gastric emptying and may affect the absorption of other medicines taken by mouth, so mixing medicines is a question for a doctor or pharmacist.
When to see a doctor about heartburn
NIDDK says to see a doctor if you think you have GERD, or if symptoms do not get better with over-the-counter medicines or lifestyle changes.
For the wider list of stomach effects, see our GLP-1 side effects guide and tirzepatide diarrhea.
Zepbound heartburn questions
Does Zepbound cause heartburn?+
Heartburn is a listed side effect. The Zepbound patient information lists heartburn among its side effects, and the prescribing information names gastroesophageal reflux disease. In the Mounjaro label (the same drug, tirzepatide), reflux disease was reported by 1.7% to 2.5% on the drug against 0.4% on placebo.
How long does Zepbound heartburn last?+
No label or study we found gives a time for reflux on tirzepatide. The Zepbound label says most people who stopped because of side effects did so in the first few months, due to stomach side effects. A 2025 joint advisory says stomach side effects are more likely at the start and when the dose goes up.
How to avoid heartburn on Zepbound?+
No study has tested a way to prevent heartburn on Zepbound. For reflux in general, NIDDK says a doctor may recommend losing weight if needed, raising the head of the bed 6 to 8 inches, and quitting smoking. A 2025 joint advisory says alcohol may worsen reflux on GLP-1 therapy.
How to stop heartburn on GLP-1?+
The GLP-1 labels do not give a treatment plan for heartburn. NIDDK says doctors may recommend antacids for mild heartburn, but that they should not be used every day or for severe symptoms without talking to a doctor. It says to see a doctor if symptoms do not get better with over-the-counter medicines or lifestyle changes.
How to get rid of heartburn with tirzepatide?+
There is no tirzepatide-specific remedy in any source we found. NIDDK describes general reflux steps: lifestyle changes a doctor may recommend, and antacids for mild heartburn, but not every day or for severe symptoms without talking to a doctor. It says to see a doctor if symptoms do not get better.
How to stop Zepbound acid reflux?+
The Zepbound label does not say how. NIDDK says to see a doctor if you think you have GERD, or if symptoms do not get better with over-the-counter medicines or lifestyle changes.
Can I take an antacid while on tirzepatide?+
No official source addresses antacids with tirzepatide directly. The Zepbound label says tirzepatide delays gastric emptying and may affect the absorption of other medicines taken by mouth. Questions about combining medicines belong with a doctor or pharmacist.
Sources: Zepbound FDA label; Mounjaro FDA label; Joint nutrition advisory, Obesity 2025; NIDDK, acid reflux symptoms and causes; NIDDK, acid reflux treatment
Related tirzepatide guides
Is Zepbound the Same as Mounjaro?
One drug, two labels
Tirzepatide Dosage Guide
The label dose chart and schedule
Tirzepatide Diarrhea
Rates by dose and timing
GLP-1 Side Effects
The side effects of the whole drug group
Zepbound and Dizziness
What the label reports
Zepbound Dry Mouth
Whether dry mouth is a listed side effect
This guide is for educational purposes only and is not medical advice. It describes what FDA labels, NIH pages and published studies report about heartburn and reflux on tirzepatide. Questions about your own symptoms or medicine belong with a licensed clinician.